Trials / Completed
CompletedNCT04336618
Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 67 (actual)
- Sponsor
- Perspectum · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek interest in participating in future studies.
Detailed description
This is a Registry where there will be no intervention to the standard of care.Participants will be required to attend a single visit that will involve having a multi-parametric MRI at no cost to them. In addition, the invesigators will collect contact information of participants including their email address, phone number and house address so that they can be contacted to discuss possible participation in future studies which may be sponsored by Perspectum or third parties, such as pharmaceutical companies, the participants personal information shall never be shared with these third-parties. Additionally, the contact information of the participants medical providers shall be collected so that, if requested, their LMS reports can be used in their diagnostic pathway. Imaging will be performed at two Touchstone Imaging locations, one in downtown Dallas and the other in Southlake. A total of 100 participants will be enrolled over a period of 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Liver MultiScan | The LiverMultiscan is a quick 15 minute, contrast free, non-invasive MRI scan that provides 3 liver metrics |
Timeline
- Start date
- 2020-08-03
- Primary completion
- 2022-09-27
- Completion
- 2022-09-27
- First posted
- 2020-04-07
- Last updated
- 2023-12-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04336618. Inclusion in this directory is not an endorsement.